thyrogen
sanofi b.v. - thyrotropin alfa - schilddrüsenneoplasmen - vorderen hypophysenlappens hormone und analoga hypophysen-und hypothalamus-hormone und analoga - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.
thyrogen poudre pour solution injectable
sanofi-aventis (suisse) sa - thyrotropinum alfa - poudre pour solution injectable - praeparatio cryodesiccata: thyrotropinum alfa 0.9 mg, mannitolum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, pro vitro corresp. natrium 1.19 mg. - krebs der schilddrüse - biotechnologika
eltroxin-lf 0.05 mg, tabletten
alfasigma schweiz ag - levothyroxinum natricum anhydricum - 0.05 mg, tabletten - levothyroxinum natricum anhydricum 50 µg ut levothyroxinum natricum, cellulosum microcristallinum, amylum pregelificatum, talcum, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 1.4 µg. - hypothyreose - synthetika
eltroxin-lf 0.1 mg, tabletten
alfasigma schweiz ag - levothyroxinum natricum anhydricum - 0.1 mg, tabletten - levothyroxinum natricum anhydricum 100 µg ut levothyroxinum natricum, cellulosum microcristallinum, amylum pregelificatum, talcum, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 2.8 µg. - hypothyreose - synthetika
siroctid 0,05 mg/ml injektionslösung in einer fertigspritze
chemi s.p.a. - octreotid acetat - octreotid
siroctid 0,1 mg/ml injektionslösung in einer fertigspritze
chemi s.p.a. - octreotid acetat - octreotid
siroctid 0,5 mg/ml injektionslösung in einer fertigspritze
chemi s.p.a. - octreotid acetat - octreotid
danokrin 200 mg - kapseln
sanofi-aventis gmbh - danazol - danazol
amiodaron aurobindo 200 mg tabletten
puren pharma gmbh & co. kg (8034441) - amiodaronhydrochlorid - tablette - teil 1 - tablette; amiodaronhydrochlorid (21609) 200 milligramm
sandostatin 0,05 mg/ml injektionslösung
novartis pharma schweiz ag - octreotidum - injektionslösung - octreotidum 0.05 mg ut octreotidi acetas, mannitolum, acidum lacticum, natrii hydrogenocarbonas q.s. ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - das somatostatin-analogon - synthetika